Masimo (NSDQ:MASI) said today that it won CE Mark approval in the European Union for its next-gen SedLine brain function monitor intended for pediatric patients. The Irvine, Calif.-based company said that with the clearance, its next-gen SedLine monitoring tech is now available for all patients one year and older in CE Mark countries. Masimo said that […]
Masimo beats The Street on Q4 earnings
Masimo (NSDQ:MASI) stock is up about 5% in value today after the Irvine, Calif.– based maker of noninvasive patient monitoring technologies and sensors reported fourth-quarter results that beat analyst expectations. Masimo reported yesterday evening that it earned $46.9 million, or 83 cents per share, off $223.1 million in revenue for the quarter ended Dec. 29. Masimo lost […]
Masimo receives FDA clearance for fingertip pulse oximeter measurement
Masimo recently announced that it has received FDA clearance for its respiration rate measurement from the pleth RRp on its MightySat Rx spot-check fingertip pulse oximeter. It was also indicated for use in the home. Using the company’s RRp in MightSat Rx, respiration rate can be measured using the same optical sensor that measures SpO2, PR, […]
Globus Medical gains on Street-beating prelims | Wall Street Beat
Globus Medical (NYSE:GMED) shares closed up yesterday after the orthopedics company reported preliminary fourth-quarter and 2018 sales numbers that beat the consensus forecast on Wall Street. Audubon, Pa.-based Globus said it expects to post Q4 revenues of $195.5 million and full-year sales of $712.5 million; analysts on The Street were looking for quarterly sales of $188.2 million and […]
Masimo inks $150m credit facility deal
Masimo (NSDQ:MASI) has inked a $150 million credit facility with JP Morgan Chase and Bank of the West, according to a recently published SEC filing. The Irvine, Calif.-based company’s new facility comes with an option to increase the aggregate borrowing capacity up to $550 million, and also provides for a sublimit of up to $25 million […]
FDA chooses 8 medtech companies for opioid crisis challenge
The FDA has selected eight medtech companies to develop devices to help reduce the country’s opioid abuse crisis. More than 250 companies submitted entries to the FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder, announced in May. Those selected include Masimo Corp. and deep-brain-stimulation company Brainsway Ltd. The companies will be expected to […]
Masimo Q3 beats The Street
Masimo (NSDQ:MASI) today released third quarter earnings that topped expectations on Wall Street and lifted its guidance for the remaining year. The Irvine, Calif.-based company posted profits of $57.1 million, or $1.02 per share, on sales of $210.6 million for the three months ended September 29, for bottom-line growth of 59.3% on sales growth of 8.9% […]
Masimo wins FDA nod for improved RD SET sensors
Masimo (NSDQ:MASI) said today it won FDA 510(k) clearance for its RD SET sensors with measure-through motion and low perfusion SET pulse oximetry. The newly cleared sensors feature improved SpO2 accuracy specifications for patients under 3kg, the Irvine, Calif.-based company said, and are designed to improve accuracy, patient comfort and clinician workflows. “We’re delighted to be […]
Where medtech is putting its money this November
Republicans reaped nearly $3.3 million in federal political contributions from the medtech industry in the 2017-18 election cycle, compared with $1.85 million for Democrats, according to data collected by the Center for Responsive Politics, a nonprofit campaign finance watchdog group. Medtech has “historically been a little more Republican than the average industry,” said Andrew Mayersohn, committees researcher […]
FDA clears Masimo’s Rainbow acoustic monitors for infants, neonates
Masimo (NSDQ:MASI) said today it won FDA clearance for its RAS-45 acoustic respiration sensor as part of its Rainbow Acoustic Monitoring system, cleared for use with infants and neonatal patients. With the clearance, the Rainbow Acoustic Monitoring system is now cleared for use with patients of all sizes, the Irvine, Calif.-based company said. Previously, the system […]
Masimo touts study exploring ORi’s ability to detect oxygenation during moderate hyperoxia
Masimo (NSDQ:MASI) today released results from a study exploring the ability of the company’s Oxygen Reserve Index (ORi) to show trends in oxygenation during moderate hyperoxia. The company’s ORi measure is intended to serve as a non-invasive, relative indicator of an individual’s oxygen reserve during moderate hypoxia. The measurement can be trended and can be used […]
- 1
- 2
- 3
- …
- 19
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube